Find uplifting stories about heroes, innovations, and solutions
984 results for "** tuberculosis vaccine"
Scientists in South Africa are leading a breakthrough tuberculosis vaccine trial that could protect adolescents and adults for the first time in over a century. The M72 vaccine, combined with faster tests and shorter treatments, marks a turning point against the world's deadliest infectious disease.
Scientists in South Africa are on the brink of developing the world's first effective tuberculosis vaccine for adolescents and adults, a breakthrough that could prevent 76 million infections globally. African leaders visited the groundbreaking research site and called for urgent investment to prepare the continent for mass vaccine rollout.
Scientists at Johns Hopkins developed a nose-delivered vaccine that helps the body fight tuberculosis, the world's deadliest infectious disease. Early tests show it could shorten treatment times and prevent drug-resistant strains.
Indian researchers have validated two groundbreaking tuberculosis vaccines that show up to 79.5% effectiveness against the disease, offering new hope for children and adults in a country carrying 27% of the world's TB burden. The vaccines demonstrate particular promise in protecting kids aged 6 to 14 from all forms of TB.
After a century with only one TB vaccine, three promising candidates are in final trials, led by South African researchers who could deliver a breakthrough by 2028. The new vaccines could prevent millions of deaths from a disease that still kills over 1.5 million people yearly.
Bryan Bryson is tackling tuberculosis, history's deadliest pathogen, by studying how immune cells fight back. His research could unlock the first effective TB vaccine for adults in a century. #
A 1920s tuberculosis vaccine is helping people with autoimmune diabetes reduce their insulin use in a breakthrough trial. The discovery adds to growing evidence that certain vaccines protect against diseases far beyond their original targets.
A Saskatchewan team has developed a groundbreaking vaccine that protects cattle from tuberculosis without interfering with disease testing. If approved, MSX-1 would be the world's first licensed bovine TB vaccine.
Since the HPV vaccine became available in 2006, cervical cancer rates have dropped 27% among young American women, with some states seeing reductions over 50%. Every 10% increase in vaccination rates translates to nearly 12% fewer cancer cases.
South Carolina's largest measles outbreak in decades has officially ended after nearly 1,000 cases, and there's encouraging news: vaccination rates are climbing both locally and nationwide. Health officials say the outbreak may have reminded parents why vaccines matter.
Scientists at Washington University have created a nose spray vaccine that completely protected mice and hamsters from bird flu infection, offering hope for preventing the next pandemic. The vaccine works better than traditional flu shots and stays effective even in people who've had previous flu vaccines.
The FDA reversed its decision and will now review Moderna's groundbreaking mRNA flu vaccine, marking a potential leap forward in flu prevention. This could bring the same technology that revolutionized COVID vaccines to seasonal flu shots.
California health officials are encouraging at-risk residents to get vaccinated against mpox as case rates have more than quadrupled compared to last year. The vaccine provides strong protection against both strains of the virus, and most new infections are happening in unvaccinated people.
A groundbreaking trial shows Moderna's new mRNA flu vaccine is 27% more effective than traditional flu shots, offering hope for better protection during flu season. The technology's faster production could mean vaccines that better match circulating strains.
African countries have prevented nearly one million cervical cancer deaths through expanded HPV vaccination programs since 2019, while new malaria vaccines are saving thousands of children across 25 nations. These historic health wins are generating $1.8 billion in economic benefits, though funding gaps now threaten to slow the momentum.
Scientists are fast-tracking three promising vaccines to fight the Ebola outbreak in Congo and Uganda, with clinical trials starting within months. New funding of $62 million is speeding up development of the first vaccines specifically designed for the Bundibugyo virus strain.
Iceland, Portugal, and Norway have reached the ambitious target of vaccinating 90% of girls against HPV by age 15, bringing cervical cancer elimination within reach. Since 2020, every European country has reported declining cervical cancer rates among vaccinated women. #
An FDA committee greenlighted next year's flu vaccine formulation this week, maintaining the proven update process while vaccine policy debates swirl in Washington. The decision keeps Americans on track for seasonal flu protection.
South Africa is expanding its lifesaving HPV vaccination campaign to reach every girl in the country, protecting them from cervical cancer that kills over 3,000 women annually. Since 2014, the program has already vaccinated 3.6 million girls with more than 7.2 million doses administered.
A tuberculosis vaccine developed 100 years ago is showing promise in helping people with type 1 diabetes use less insulin and maintain better blood sugar control. While more research is needed, the results offer new hope for the 2 million Americans living with this challenging autoimmune disease.
Showing 20 of 984